Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
According to NewsNation, Trump said he spoke late last night by phone with Hegseth, an aid to the US defense secretary, to discuss Iran.
2026-09-03
According to NewsNation, Trump said he spoke late last night by phone with Hegseth, an aid to the US defense secretary, to discuss Iran.
Back
Other News
2026-09-02
BOC Governor Macklem said if monetary policy fails to achieve its objective, markets will reprice.
BOC Governor Macklem said if monetary policy fails to achieve its objective, markets will reprice.
2026-09-03
[Gan & Lee Pharmaceuticals: GZC8072 Tablets Receive Approval for Clinical Trials in Type 2 Diabetes] Gan & Lee Pharmaceuticals announced that its wholly-owned subsidiary, Gan & Lee Pharmaceuticals Shandong Co., Ltd., recently received a "Drug Clinica
[Gan & Lee Pharmaceuticals: GZC8072 Tablets Receive Approval for Clinical Trials in Type 2 Diabetes] Gan & Lee Pharmaceuticals announced that its wholly-owned subsidiary, Gan & Lee Pharmaceuticals Shandong Co., Ltd., recently received a "Drug Clinical Trial Approval Notice" from the National Medical Products Administration (NMPA) for a new indication of GZC8072 tablets, approving the conduct of clinical trials for type 2 diabetes. The next phase of clinical trials for this product will be conducted in accordance with relevant national drug registration regulations.
Chat with us
, powered by
LiveChat